乳房画像診断の世界市場：2025年～2033年

乳房画像診断技術の進歩は、診断精度の向上、患者の転帰の改善、アクセシビリティの向上により、市場の成長を大きく後押ししています。デジタルマンモグラフィ、3Dトモシンセシス、AIエンハンスド・イメージングなどの技術は、密な乳腺組織であっても、偽陽性を最小限に抑えながら、より早期かつ正確な検出を可能にします。例えば、OSF HealthCareは2024年8月、ペルーのセント・エリザベス・メディカル・センターでInvenia ABUS 2.0（Automated Breast Ultrasound System）を導入し、乳がん検診の技術的進歩を大きく示しました。Invenia ABUS 2.0は、乳腺組織の密度が高いためにマンモグラフィでは隠れてしまうがんを検出するために特別に設計されており、密な組織もがん腫瘤も白く見えます。

同様に、2022年6月、Seno Medicalの乳房画像診断システムは米国食品医薬品局（FDA）の機器・放射線保健センター（CDRH）から市販前承認（PMA）を追認されました。Seno Medicalの乳房画像診断システムは、乳房画像診断における重要な技術的進歩を象徴するものです。この革新的なシステムは、光音響（OA）と超音波（米国）の技術を組み合わせて利用し、乳房病変に関するリアルタイムの情報を提供します。

また、ヘルスケアプロバイダーや患者が早期かつ正確な診断の重要性を認識するにつれて、先進的なソリューションに対する需要が急増しています。技術の進歩に伴い、質の高い画像診断へのアクセスは、十分なサービスを受けていない地域を含め、世界的に向上しています。新たな画像モダリティやAIの継続的な研究が市場成長をさらに後押しし、より多くの女性が早期発見イニシアチブの恩恵を受けられるようになり、乳がんの検出と治療における継続的な進歩が促進されます。

当レポートでは、世界の乳房画像診断市場について調査し、市場の概要とともに、タイプ別、技術別、用途別、エンドユーザー別、地域別動向、競合情勢、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 調査手法と範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 影響要因
  • 促進要因
  • 抑制要因
  • 機会
• 影響分析

第5章 戦略的洞察と業界展望

• 市場のリーダーと先駆者
• CXOの視点
• 最新の開発とブレークスルー
• ケーススタディ/進行中の調査
• 規制と償還の情勢
• ポーターのファイブフォース分析
• サプライチェーン分析
• 特許分析
• SWOT分析
• アンメットニーズとギャップ
• 市場参入と拡大のための推奨戦略
• シナリオ分析ベストケース、ベースケース、ワーストケースの予測
• 価格分析と価格動向
• キーオピニオンリーダー

第6章 タイプ別

• スクリーニングマンモグラフィ
• 診断用マンモグラフィ
• 乳房トモシンセシス
• 乳房超音波検査
• 乳房MRI

第7章 技術別

• コンピュータ断層撮影（CT）スキャン
• 磁気共鳴画像（MRI）スキャン
• 超音波
• 陽電子放出断層撮影（PET）スキャン
• その他

第8章 用途別

• 乳房疾患
• 乳がん
• 良性腫瘍
• 嚢胞
• その他

第9章 エンドユーザー別

• 病院
• 診断センター
• 研究機関
• その他

第10章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • スペイン
  • イタリア
  • その他
• 南米
  • ブラジル
  • アルゼンチン
  • その他
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他
• 中東・アフリカ

第11章 競合情勢

第12章 企業プロファイル

• GE HealthCare
• Koning Health
• FUJIFILM Holdings Corporation
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
• Hologic, Inc.
• Siemens Healthineers AG
• Agfa-Gevaert Group.
• Koninklijke Philips NV
• Planmed Oy
• Seno Medical

第13章 付録

The global breast imaging market reached US$ 4.74 billion in 2024 and is expected to reach US$ 9.77 billion by 2033, growing at a CAGR of 8.43% during the forecast period 2025-2033.

Breast imaging encompasses a variety of diagnostic techniques aimed at visualizing and evaluating breast tissue to identify abnormalities such as lumps, cysts, or signs of breast cancer. These methods are essential for early detection, diagnosis, and monitoring of breast conditions, thereby facilitating timely and effective treatment interventions.

Market Dynamics: Drivers & Restraints

Rising technological advancements

Advancements in breast imaging technologies are significantly propelling market growth by enhancing diagnostic accuracy, improving patient outcomes, and increasing accessibility. Technologies like digital mammography, 3D tomosynthesis, and AI-enhanced imaging enable earlier and more precise detection, even in dense breast tissue, while minimizing false positives. For instance, in August 2024, OSF HealthCare introduced the Invenia ABUS 2.0 (Automated Breast Ultrasound System) at its Saint Elizabeth Medical Center in Peru, marking a significant technological advancement in breast cancer screening. The Invenia ABUS 2.0 is specifically designed to detect cancers that may be hidden on mammograms due to the density of breast tissue, where both dense tissue and cancerous masses appear white.

Similarly, in June 2022, Seno Medical's Imagio Breast Imaging System received supplemental premarket approval (PMA) from the Center for Devices and Radiological Health (CDRH) of the US Food & Drug Administration (FDA). The Imagio Breast Imaging System by Seno Medical represents a significant technological advancement in breast imagingThis innovative system utilizes a combination of opto-acoustic (OA) and ultrasound (US) technologies to provide real-time information about breast lesions.

Additionally, the demand for advanced solutions is surging as healthcare providers and patients recognize the importance of early and accurate diagnosis. As technology progresses, access to high-quality imaging is improving globally, including in underserved regions. Continuous research into new imaging modalities and AI applications further propels market growth, ensuring more women can benefit from early detection initiatives and fostering ongoing advancements in breast cancer detection and treatment.

High costs associated with breast imaging systems

The high costs associated with breast imaging systems present a significant challenge to the growth of the market. For instance, digital mammography systems can range from $65,000 to $95,000, depending on the model and manufacturer. The high upfront investment required for purchasing and maintaining equipment such as digital mammography machines, MRI systems, and 3D tomosynthesis devices can be a significant financial burden for hospitals, clinics, and healthcare providers.

Segment Analysis

The global Breast Imaging market is segmented based on technology, end-user, and region.

Technology:

Magnetic resonance imaging (MRI) segment is expected to dominate the global Breast Imaging market share

The Magnetic Resonance Imaging (MRI) segment dominates the breast imaging market due to its advanced imaging capabilities and non-invasive nature. Innovations such as 3D MRI and contrast-enhanced MRI significantly enhance the effectiveness of breast cancer detection, particularly for women with dense breast tissue or those at high risk. For instance, in October 2022, Intermountain Healthcare is launching an abbreviated MRI screening tool specifically designed for women at higher risk of developing breast cancer. This development marks a significant advancement in the MRI segment of breast imaging, as it offers a targeted approach to enhance early detection in populations that may not benefit as much from traditional mammography. These advancements allow healthcare providers to deliver more accurate and detailed diagnostic options, leading to improved patient outcomes. The high sensitivity and specificity of MRI are crucial for early detection and effective management of breast cancer, making it a preferred choice in clinical settings.

The increasing prevalence of breast cancer drives the adoption of MRI in breast imaging. According to the World Health Organization report, In 2022, there were 2.3 million women diagnosed with breast cancer. The incidence is expected to increase which is increasing the urgent need for advanced imaging technologies like MRI. As healthcare systems emphasize early detection and preventive care, the demand for MRI continues to rise, positioning it as a leading segment in the breast imaging market. The combination of technological advancements and growing awareness about breast cancer screening underscores MRI's pivotal role in enhancing diagnostic capabilities and improving patient care.

Geographical Analysis

North America is expected to hold a significant position in the global breast imaging market share

North America is expected to hold a significant position in the global breast imaging market due to several key factors. Advancements in medical technology, particularly in imaging techniques like 3D mammography, ultrasound, and MRI, are crucial factors in maintaining North America's dominant position in the breast imaging market. As these technologies evolve, healthcare providers in the region can offer more precise, non-invasive, and effective diagnostic options.

The region's continued development of cutting-edge technologies helps solidify its leadership in the global breast imaging market, ensuring that healthcare providers have access to the latest tools for early detection and improved treatment. For instance, Seno Medical Instruments officially launched the commercially available Imagio Breast Imaging System at RSNA in November 2022, marking a significant development for breast cancer diagnostics in North America. This innovative system utilizes a combination of optoacoustic and ultrasound technology to provide real-time information about breast lesions, enabling radiologists to differentiate between benign and malignant masses more effectively.

Key market players are driving the growth of the breast imaging market in North America by focusing on technological advancements, strategic partnerships, and expanding their product portfolios. For instance, in December 2024, QT Imaging Holdings, Inc. announced the expansion of its Breast Acoustic CT Scanner to the Couri Center for Gynecology and Integrative Women's Health in Peoria, IL. This strategic initiative, executed in partnership with NXC Imaging, Inc., enhances access to innovative breast imaging technology that prioritizes patient comfort and safety while delivering high-quality diagnostic capabilities. The rising demand for breast imaging in both diagnostic and treatment applications has created significant growth opportunities for manufacturers in North America. Thus, the above factors are expected to hold the region in the dominant position.

Competitive Landscape

The major global players in the Breast Imaging market include Bayer AG, Pfizer, Inc., AbbVie, Inc, AstraZeneca, Gedeon Richter Plc., TORRENT PHARMACEUTICALS LTD., Sanofi SA, Gynogen, and Weefsel Pharma among others.

Key Developments

• In August 2024, Izotropic Corporation announced that it is pursuing a regulatory strategy in the U.S. and EU to launch IzoView as a diagnostic device indicated for use in patients with dense breast tissue.
• In June 2023, Koning Corporation launched adjunctive artificial intelligence (AI) software that can produce 3D CT breast images through seamless integration with the company's existing breast CT devices.
• In January 2023, Izotropic Corporation announced that IzoView will be featured on an upcoming segment of Advancements with Ted Danson ("Advancements") via Amazon Prime Video and Bloomberg TV.

Why Purchase the Report?

• Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The Global Breast Imaging Market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Type
• 3.2. Snippet by Technology
• 3.3. Snippet by Application
• 3.4. Snippet by End-User
• 3.5. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Rising technological advancements
  • 4.1.2. Restraints
    • 4.1.2.1. High costs associated with breast imaging systems
  • 4.1.3. Opportunity
• 4.2. Impact Analysis

5. Strategic Insights and Industry Outlook

• 5.1. Market Leaders and Pioneers
  • 5.1.1. Emerging Pioneers and Prominent Players
  • 5.1.2. Established leaders with largest selling Brand
  • 5.1.3. Market leaders with established Product
• 5.2. CXO Perspectives
• 5.3. Latest Developments and Breakthroughs
• 5.4. Case Studies/Ongoing Research
• 5.5. Regulatory and Reimbursement Landscape
  • 5.5.1. North America
  • 5.5.2. Europe
  • 5.5.3. Asia Pacific
  • 5.5.4. Latin America
  • 5.5.5. Middle East & Africa
• 5.6. Porter's Five Force Analysis
• 5.7. Supply Chain Analysis
• 5.8. Patent Analysis
• 5.9. SWOT Analysis
• 5.10. Unmet Needs and Gaps
• 5.11. Recommended Strategies for Market Entry and Expansion
• 5.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
• 5.13. Pricing Analysis and Price Dynamics
• 5.14. Key Opinion Leaders

6. By Type

• 6.1. Introduction
  • 6.1.1. Analysis and Y-o-Y Growth Analysis (%), By Type
  • 6.1.2. Market Attractiveness Index, By Type
• 6.2. Screening Mammography*
  • 6.2.1. Introduction
  • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 6.3. Diagnostic Mammography
• 6.4. Breast Tomosynthesis
• 6.5. Breast Ultrasound
• 6.6. Breast MRIs

7. By Technology

• 7.1. Introduction
  • 7.1.1. Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 7.1.2. Market Attractiveness Index, By Technology
• 7.2. Computed Tomography (CT) Scan*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Magnetic Resonance Imaging (MRI) Scan
• 7.4. Ultrasound
• 7.5. Positron Emission Tomography (PET) Scan
• 7.6. Others

8. By Application

• 8.1. Introduction
  • 8.1.1. Analysis and Y-o-Y Growth Analysis (%), By Application
  • 8.1.2. Market Attractiveness Index, By Application
• 8.2. Breast Disease*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Breast Cancers
• 8.4. Benign Tumors
• 8.5. Cysts
• 8.6. Others

9. By End-User

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 9.1.2. Market Attractiveness Index, By End-User
• 9.2. Hospitals*
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 9.3. Diagnostic Centers
• 9.4. Research Institutes
• 9.5. Others

10. By Region

• 10.1. Introduction
  • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 10.1.2. Market Attractiveness Index, By Region
• 10.2. North America
  • 10.2.1. Introduction
  • 10.2.2. Key Region-Specific Dynamics
  • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.2.5.1. U.S.
    • 10.2.5.2. Canada
    • 10.2.5.3. Mexico
• 10.3. Europe
  • 10.3.1. Introduction
  • 10.3.2. Key Region-Specific Dynamics
  • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.3.5.1. Germany
    • 10.3.5.2. U.K.
    • 10.3.5.3. France
    • 10.3.5.4. Spain
    • 10.3.5.5. Italy
    • 10.3.5.6. Rest of Europe
• 10.4. South America
  • 10.4.1. Introduction
  • 10.4.2. Key Region-Specific Dynamics
  • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.4.5.1. Brazil
    • 10.4.5.2. Argentina
    • 10.4.5.3. Rest of South America
• 10.5. Asia-Pacific
  • 10.5.1. Introduction
  • 10.5.2. Key Region-Specific Dynamics
  • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.5.5.1. China
    • 10.5.5.2. India
    • 10.5.5.3. Japan
    • 10.5.5.4. South Korea
    • 10.5.5.5. Rest of Asia-Pacific
• 10.6. Middle East and Africa
  • 10.6.1. Introduction
  • 10.6.2. Key Region-Specific Dynamics
  • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

• 11.1. Competitive Scenario
• 11.2. Market Positioning/Share Analysis
• 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

Key Market Players

• 12.1. GE HealthCare*
  • 12.1.1. Company Overview
  • 12.1.2. Product Portfolio
    • 12.1.2.1. Product Description
    • 12.1.2.2. Product Key Performance Indicators (KPIs)
    • 12.1.2.3. Historic and Forecasted Product Sales
    • 12.1.2.4. Product Sales Volume
  • 12.1.3. Financial Overview
    • 12.1.3.1. Company Revenue's
    • 12.1.3.2. Geographical Revenue Shares
    • 12.1.3.3. Revenue Forecasts
  • 12.1.4. Key Developments
    • 12.1.4.1. Mergers & Acquisitions
    • 12.1.4.2. Key Product Development Activities
    • 12.1.4.3. Regulatory Approvals etc.
  • 12.1.5. SWOT Analysis
• 12.2. Koning Health
• 12.3. FUJIFILM Holdings Corporation
• 12.4. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
• 12.5. Hologic, Inc.
• 12.6. Siemens Healthineers AG
• 12.7. Agfa-Gevaert Group.
• 12.8. Koninklijke Philips N.V.
• 12.9. Planmed Oy
• 12.10. Seno Medical
• Similar data will be provided for each market player.

LIST NOT EXHAUSTIVE

13. Appendix

• 13.1. About Us and Services
• 13.2. Contact Us